The Relationship of Hemoglobin A1c and Diabetic Wound Healing

Stopped early · Phase 4

Conditions studied: Diabetes, Type 1, Diabetes, Type 2, Foot Ulcer, Diabetic

In brief

The purpose of this study is to investigate the relationship of hemoglobin A1c in diabetic wound healing. Additionally, a comparison of two wound dressings, AmeriGel® (Amerx Health Care Corp., Clearwater, FL) and Bacitracin, with and without vitamin C supplementation, will be done to evaluate impact on time to wound closure.

Key facts

Study ID

NCT01350102

Run by

Susan Hassenbein

People needed

2

Starts

2012-02-01

Expected to finish

2014-03-01

Last updated by the study team

2017-12-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• >18 years of age
• Diabetic (Type I and Type II)
• Ulceration of the foot at least one centimeter in width/length
• Ulceration at least 0.2 centimeters in depth

You may not qualify if…

• Ulceration width/length > 7.5 centimeters
• Wound depth > 1.25 centimeters
• Purulent, excessive drainage and/or other signs of infection (i.e. erythema, edema, warmth)
• Inability to provide informed consent
• Inability to swallow pills (vitamin C supplement)
• Patients with concurrent renal problems
• Patients with medication contraindications to Vitamin C and/or topical wound dressings

Where it is running

• Penn State Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.